
Sign up to save your podcasts
Or


In the mid-1990s, the idea of a genome-scale study seemed impossible or even crazy to some. Dr. Lou Staudt (director of NCI’s Center for Cancer Genomics) talks about putting together one of the first cancer genomic studies for diffuse large B-cell lymphoma and building the “Lymphochip” microarray.
By National Cancer InstituteIn the mid-1990s, the idea of a genome-scale study seemed impossible or even crazy to some. Dr. Lou Staudt (director of NCI’s Center for Cancer Genomics) talks about putting together one of the first cancer genomic studies for diffuse large B-cell lymphoma and building the “Lymphochip” microarray.